These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 25088942)

  • 1. Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.
    de la Monte SM
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1954-60. PubMed ID: 25088942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
    de la Monte SM
    Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
    de la Monte SM; Tong M
    J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
    Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
    J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metabolic dysfunction at the core of Alzheimer's disease.
    de la Monte SM; Tong M
    Biochem Pharmacol; 2014 Apr; 88(4):548-59. PubMed ID: 24380887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
    Moroz N; Tong M; Longato L; Xu H; de la Monte SM
    J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and Alzheimer's disease.
    de la Monte SM
    BMB Rep; 2009 Aug; 42(8):475-81. PubMed ID: 19712582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
    Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
    Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.
    Guerrero-Berroa E; Schmeidler J; Beeri MS
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1961-6. PubMed ID: 24529419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.
    De Sousa RAL; Harmer AR; Freitas DA; Mendonça VA; Lacerda ACR; Leite HR
    Mol Biol Rep; 2020 Aug; 47(8):6347-6356. PubMed ID: 32740795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes?
    Kubis-Kubiak AM; Rorbach-Dolata A; Piwowar A
    Mech Ageing Dev; 2019 Jul; 181():7-21. PubMed ID: 31085195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
    Zhao WQ; Townsend M
    Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?
    de la Monte SM
    J Alzheimers Dis; 2024; 101(s1):S317-S343. PubMed ID: 39422949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.